Objectives:

1. Present infomration about current understanding of checkpoint inhibitors and current use of immune checkpoint inhibitor (ICI) therapy.

2. Discuss current literature about rheumatologic immune-related adverse events (irAEs) via various retrospective case series.

3. Propose some initiatives for further investigation and future research related to Rheumatologic irAEs.

Session date: 
Tuesday, September 26, 2017 - 8:30am to 9:30am
Speaker Name: 
Pankti Reid, M.D., M.P.H.
Location: 
UCMC
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.